Chronic migraine often causes children and teens to miss both school and extracurricular activities. Hear 14-year old I’yyonce describe her experience with ongoing migraines.
Biohaven Pharmaceuticals is studying an investigational drug to potentially treat migraines in children and teens. If your child is between 6 and 17 years of age and has at least a 6-month history of migraine, they may qualify. Learn more about our pediatric migraine study.